AlphaFold predicted structure
RERE · Q9P2R6

Mean pLDDT
53.3/ 100
Low
1,566 residues
Confidence breakdown
- Very high(≥ 90)10%
- Confident(70–90)20%
- Low(50–70)9%
- Very low(< 50)61%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
arginine-glutamic acid dipeptide repeats
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownStructural eye disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownClefting
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedneurodevelopmental disorder with or without anomalies of the brain, eye, or heart
hereditary disease
asthma
hypothyroidism
complex neurodevelopmental disorder with or without congenital anomalies
dermatophytosis
spondylosis
knee injury
Neck pain
allergic disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Arginine-glutamic acid dipeptide repeats protein
Plays a role as a transcriptional repressor during development. May play a role in the control of cell survival. Overexpression of RERE recruits BAX to the nucleus particularly to POD and triggers caspase-3 activation, leading to cell death
RERE · Q9P2R6

Mean pLDDT
53.3/ 100
Low
1,566 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0